Multiples Myelom: Neues Triplettregime mit Carfilzomib
Oncol Res Treat 2021;44:284 –285 (Source: Oncology Research and Treatment)
Source: Oncology Research and Treatment - May 5, 2021 Category: Cancer & Oncology Source Type: research
CLL: Viele Vorteile mit Acalabrutinib
Oncol Res Treat 2021;44:282 –283 (Source: Oncology Research and Treatment)
Source: Oncology Research and Treatment - May 5, 2021 Category: Cancer & Oncology Source Type: research
Efficacy of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in the Adjuvant Setting for Patients with Resected Epidermal Growth Factor Receptor Mutant Non-Small Cell Lung Cancer: A Meta-Analysis with 11 Trials
Conclusion: Our meta-analysis results suggested that EGFR-TKI treatment improved the DFS and OS of completely resected patients with EGFR-mutant NSCLC compared with non-EGFR-TKI treatment in the adjuvant setting. In the future, our conclusion should be confirmed by additional large-scale and well-designed clinical trials.Oncol Res Treat (Source: Oncology Research and Treatment)
Source: Oncology Research and Treatment - May 5, 2021 Category: Cancer & Oncology Source Type: research
Retrospective Analysis of the Clinical Presentation, Treatment and Outcome of Angiosarcoma in a Sarcoma Referral Center
Conclusion: AS is a very heterogeneous sarcoma subtype, with substantial variability in clinical presentation and survival among patient subsets. Prognosis is poor, and there is no difference in outcome comparing the 2 most frequently used chemotherapy agents in the first line, paclitaxel and doxorubicin.Oncol Res Treat (Source: Oncology Research and Treatment)
Source: Oncology Research and Treatment - May 4, 2021 Category: Cancer & Oncology Source Type: research
The Poor Prognosis of Patients with Stage III Gastric Cancer after D2 Dissection Is Mainly due to Lymphatic Metastasis, Especially the Metastasis of No.12a LN: A Nested Case-Control Study
Conclusions: The poor prognosis of patients with stage III GC after D2 dissection is mainly due to lymphatic metastasis. The status of LN metastasis in the prognostic value of GC needs to be further enhanced in present staging systems. Maybe the metastasis of No.12a LN is the most significant poor prognostic factor of these patients. It points out that the dissection of No.12a LN should be carefully performed in radical gastrectomy.Oncol Res Treat (Source: Oncology Research and Treatment)
Source: Oncology Research and Treatment - May 4, 2021 Category: Cancer & Oncology Source Type: research
